Gogna et al. (2022). Spirulina- An Edible Cyanobacterium with Potential Therapeutic Health Benefits and Toxicological Consequences. Journal of the American Nutrition Association, 42, 6, 559-572.
Zhang et al. (2022). Microalgae-based oral microcarriers for gut microbiota homeostasis and intestinal protection in cancer radiotherapy. Nature Communications, 13, 1413.
Satyaraj et al. (2021). Supplementation of Diets With Spirulina Influences Immune and Gut Function in Dogs. Frontiers in Nutrition, 8.
Joventino et al. (2012). The Microalga Spirulina platensis Presents Anti-inflammatory Action as well as Hypoglycemic and Hypolipidemic Properties in Diabetic Rats. Journal of Complementary and Integrative Medicine, 9, 1.
Deng & Chow (2010). Hypolipidemic, Antioxidant, and Antiinflammatory Activities of Microalgae Spirulina. Cardiovascular Therapeutics, 28, 4, e33-45.
Kulshreshtha et al. (2008). Spirulina in health care management. Current Pharmaceutical Biotechnology, 9, 5, 400-405.
Zhang et al. (2001). Chemo- and radio-protective effects of polysaccharide of Spirulina platensis on hemopoietic system of mice and dogs. Acta Pharmacologica Sinica, 22, 12, 1121-4.